First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial
Title:
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial
Author:
Morscher, Raphael J. Brard, Caroline Berlanga, Pablo Marshall, Lynley V. André, Nicolas Rubino, Jonathan Aerts, Isabelle De Carli, Emilie Corradini, Nadège Nebchi, Souad Paoletti, Xavier Mortimer, Peter Lacroix, Ludovic Pierron, Gaelle Schleiermacher, Gudrun Vassal, Gilles Geoerger, Birgit